Novartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapies

Read post on thestar.com.my

(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases. Read full story